A patient has a congenital deficiency in factor XIII (fibrin-stabilizing factor). What would analysis of his blood reveal?
First, the core concept. Factor XIII is part of the coagulation cascade, specifically involved in stabilizing the fibrin clot. Without it, the clot isn't stable. That's probably the main point here.
The correct answer would relate to clot instability. The options might include things like prolonged PT, aPTT, or maybe issues with clot formation. Wait, the question is about what blood analysis would show. In factor XIII deficiency, PT and aPTT are usually normal because those tests don't involve factor XIII. But the clot might lyse easily, so maybe the blood clot doesn't hold up under stress tests like thrombin time or clot stability tests.
Now, the wrong options. Common mistakes could be confusion with other clotting factors. For example, factor VIII deficiency (like hemophilia A) would prolong aPTT. Factor V or prothrombin deficiency would affect PT. So if the options include those, they're incorrect. Also, maybe someone might think platelet function is affected, but factor XIII is a coagulation factor, not platelet-related.
The clinical pearl here is that factor XIII deficiency is rare but leads to unstable clots, so even if PT and aPTT are normal, there's a bleeding tendency. The key test is a clot stability test, which would show a rapidly dissolving clot.
Putting it all together, the correct answer would be something about clot instability, not affecting PT or aPTT. The options need to be labeled properly. Let me check the structure again to make sure each section is covered and within the character limit.
**Core Concept**
Factor XIII (fibrin-stabilizing factor) is a transglutaminase enzyme that cross-links fibrin polymers, forming a stable blood clot. Its deficiency leads to structurally unstable clots, resulting in abnormal bleeding despite normal clotting times. This condition is rare but clinically significant.
**Why the Correct Answer is Right**
In factor XIII deficiency, the clot formed during coagulation lacks cross-linked fibrin, making it prone to lysis. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) remain normal because these tests do not assess clot stability. The diagnosis is confirmed via a clot solubility test, where the unstable clot dissolves in urea or hydrazine. Clinical manifestations include delayed postpartum hemorrhage, intracranial hemorrhage, and wound dehiscence.
**Why Each Wrong Option is Incorrect**
**Option A:** Prolonged PT or aPTT is incorrect because these tests do not detect factor XIII deficiency.
**Option B:** Decreased platelet count is unrelated; factor XIII is a coagulation factor, not a platelet component.
**Option C:** Elevated D-dimer levels are not specific to factor XIII deficiency and occur in conditions like disseminated intravascular coagulation (DIC).
**Clinical Pearl / High-Yield Fact**
Factor XIII deficiency is a "hidden" bleeding disorder—PT and aPTT are normal, but clots are unstable. Always consider it in cases of unexplained postpartum hemorrhage or recurrent miscarriage. Diagnosis requires specialized clot solub